Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.12
-0.05 (-0.81%)
At close: Aug 15, 2025, 3:59 PM
6.09
-0.41%
After-hours: Aug 15, 2025, 07:47 PM EDT

Solid Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-154.08M -139.68M -124.7M -102.44M -90.69M -90.25M -96.02M -90.83M -90.26M -90.72M -85.98M -89.44M -87.01M -80.62M -72.19M -74.94M -78.2M -78.5M
Depreciation & Amortization
812K 2.54M 2.46M 2.55M 2.74M 2.21M 2.96M 2.91M 2.76M 2.78M 2.41M 2.63M 2.94M 2.94M 2.96M 3M 3.02M 3.63M
Stock-Based Compensation
13.3M 12.25M 10.52M 8.64M 7.27M 7.12M 7.63M 7.27M 7.17M 7.04M 7.54M 9.37M 11.26M 13.08M 13.37M 12.48M 11.82M 11.43M
Other Working Capital
2.02M 3.57M 645K -2.66M -2.43M -4.15M -5.3M -454K -4.85M 4.31M 1.34M -4.56M -5.54M -15.3M -12.64M 10.59M 14.68M 18.92M
Other Non-Cash Items
13.14M 11.39M 8.86M 4.17M 20.75M 43.23M 43.65M 23.31M 3.94M -18.84M -18.25M 844K 1.4M 1.5M 1.13M 16.72M 17.48M 17.47M
Deferred Income Tax
n/a n/a n/a -2.98M -23.32M -46.06M -46.06M -43.08M -22.74M n/a n/a n/a n/a n/a n/a -16.18M -16.18M -16.18M
Change in Working Capital
4.22M 6.84M 2.85M -1.14M -2.12M -7.63M -6.34M -7.42M -11.24M 960K -3.69M -7.77M -10.95M -20.48M -23.04M 3.34M 10.63M 14.74M
Operating Cash Flow
-122.61M -106.67M -100.01M -91.19M -85.38M -91.38M -94.18M -107.84M -110.37M -98.78M -97.98M -84.37M -82.37M -83.59M -77.76M -55.58M -52.72M -48.69M
Capital Expenditures
-722K -631K -654K -540K -908K -1.16M -1.51M -2.28M -2.74M -3.34M -3.02M -2.82M -2.22M -1.43M -1.28M -681K -524K -253K
Cash Acquisitions
n/a n/a n/a -45.39M -21.13M 26.56M 26.56M 103.47M 79.82M 90.58M 90.58M 59.06M 58.46M n/a n/a n/a n/a n/a
Purchase of Investments
-229.58M -186.33M -204.34M -203.62M -152.4M -200.77M -117.43M -122.43M -138.64M -173.88M -182.76M -179.83M -205.57M -150.13M -141.25M -124.57M -48.37M n/a
Sales Maturities Of Investments
197.6M 181.9M 188.9M 194.8M 130.3M 135.87M 128.63M 123.68M 179.29M 203.77M 212.81M 205.28M 143.6M 98.25M 51.44M 3.93M n/a 400K
Other Investing Acitivies
85K n/a 5K 45.39M 21.14M -26.56M 11.2M 1.25M 41.25M 30.49M 30.65M 26.05M -61.97M -51.88M -89.81M -120.64M -48.37M 400K
Investing Cash Flow
-32.62M -5.06M -16.09M -9.36M -23M -66.06M 9.69M 30.49M 70.04M 58.67M 59.16M 23.23M -64.19M -53.31M -91.09M -121.32M -48.89M 147K
Debt Repayment
-525K -608K -473K -345K -225K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a 78K 78K 78K 78K -1K -1K -1K -1K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
128.07M 127.73M 122.91M 493K -4.9M -4.68M 148K 2.26M 2.26M 2.26M 2.28M 160K 164K 100K 107K 41K 38K 29K
Financial Cash Flow
198.32M 204.92M 122.44M 116M 112.75M 110.36M 3.12M 77.35M 77.35M 74.81M 74.83M 160K 164K -147K 134.99M 263.62M 263.62M 263.85M
Net Cash Flow
43.09M 93.12M 6.26M 15.38M 4.29M -47.08M -81.37M 10K 37.02M 34.7M 36.01M -60.98M -146.39M -137.04M -33.87M 86.71M 162M 215.31M
Free Cash Flow
-123.34M -107.3M -100.67M -91.73M -86.29M -92.53M -95.69M -110.12M -113.11M -102.12M -100.99M -87.19M -84.58M -85.02M -79.05M -56.26M -53.25M -48.94M